FDA strikes cautious tone ahead of vaccine booster meeting
By LAURAN NEERGAARD and MATTHEW PERRONE Associated Press WASHINGTON (AP) — U.S. government advisers will debate Friday if there’s enough proof that a booster dose of Pfizer’s COVID-19 vaccine is safe and effective. It’s the first public step toward deciding which Americans may get an extra dose and when. The Food and Drug Administration on
Continue Reading